These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 27960539)
1. C-X-C Chemokine Receptor Type 4 Plays a Crucial Role in Mediating Oxidative Stress-Induced Podocyte Injury. Mo H; Wu Q; Miao J; Luo C; Hong X; Wang Y; Tang L; Hou FF; Liu Y; Zhou L Antioxid Redox Signal; 2017 Aug; 27(6):345-362. PubMed ID: 27960539 [TBL] [Abstract][Full Text] [Related]
2. CXCR4 induces podocyte injury and proteinuria by activating β-catenin signaling. Mo H; Ren Q; Song D; Xu B; Zhou D; Hong X; Hou FF; Zhou L; Liu Y Theranostics; 2022; 12(2):767-781. PubMed ID: 34976212 [No Abstract] [Full Text] [Related]
3. Wnt/β-catenin links oxidative stress to podocyte injury and proteinuria. Zhou L; Chen X; Lu M; Wu Q; Yuan Q; Hu C; Miao J; Zhang Y; Li H; Hou FF; Nie J; Liu Y Kidney Int; 2019 Apr; 95(4):830-845. PubMed ID: 30770219 [TBL] [Abstract][Full Text] [Related]
4. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury. Chen X; Liu W; Xiao J; Zhang Y; Chen Y; Luo C; Huang Q; Peng F; Gong W; Li S; He X; Zhuang Y; Wu N; Liu Y; Wang Y; Long H FASEB J; 2020 Oct; 34(10):13300-13316. PubMed ID: 32786113 [TBL] [Abstract][Full Text] [Related]
5. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress. Raij L; Tian R; Wong JS; He JC; Campbell KN Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373 [TBL] [Abstract][Full Text] [Related]
6. The CXCR4-AT1 axis plays a vital role in glomerular injury via mediating the crosstalk between podocyte and mesangial cell. Wu Q; Zhou S; Xu D; Meng P; Chen Q; Wang X; Li X; Chen S; Ye H; Ye W; Xiong Y; Li J; Miao J; Shen W; Lin X; Hou FF; Liu Y; Zhang Y; Zhou L Transl Res; 2024 Feb; 264():15-32. PubMed ID: 37696390 [TBL] [Abstract][Full Text] [Related]
7. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease. Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1. Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352 [TBL] [Abstract][Full Text] [Related]
9. Fn14 in podocytes and proteinuric kidney disease. Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007 [TBL] [Abstract][Full Text] [Related]
10. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752 [TBL] [Abstract][Full Text] [Related]
11. The receptor of advanced glycation end products plays a central role in advanced oxidation protein products-induced podocyte apoptosis. Zhou LL; Cao W; Xie C; Tian J; Zhou Z; Zhou Q; Zhu P; Li A; Liu Y; Miyata T; Hou FF; Nie J Kidney Int; 2012 Oct; 82(7):759-70. PubMed ID: 22622498 [TBL] [Abstract][Full Text] [Related]
12. The Krüppel-like factor 15-NFATc1 axis ameliorates podocyte injury: a novel rationale for using glucocorticoids in proteinuria diseases. Dou C; Zhang H; Ke G; Zhang L; Lian Z; Chen X; Zhao X; Chen Y; Li R; Ma J; Li Z; Lin T; Wang W; Ye ZM; Liang X; Shi W; Zhang B; Liu S Clin Sci (Lond); 2020 Jun; 134(12):1305-1318. PubMed ID: 32478397 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease. Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000 [TBL] [Abstract][Full Text] [Related]
14. Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease. Egerman MA; Wong JS; Runxia T; Mosoyan G; Chauhan K; Reyes-Bahamonde J; Anandakrishnan N; Wong NJ; Bagiella E; Salem F; Meliambro K; Li H; Azeloglu EU; Coca SG; Campbell KN; Raij L FASEB J; 2020 Dec; 34(12):16191-16204. PubMed ID: 33070369 [TBL] [Abstract][Full Text] [Related]
15. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Shibata S; Nagase M; Yoshida S; Kawachi H; Fujita T Hypertension; 2007 Feb; 49(2):355-64. PubMed ID: 17200434 [TBL] [Abstract][Full Text] [Related]
16. Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy. Yi M; Zhang L; Liu Y; Livingston MJ; Chen JK; Nahman NS; Liu F; Dong Z Am J Physiol Renal Physiol; 2017 Jul; 313(1):F74-F84. PubMed ID: 28404589 [TBL] [Abstract][Full Text] [Related]
17. CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling. Yoshioka T; Kosugi T; Masuda T; Watanabe T; Ryuge A; Nagaya H; Maeda K; Sato Y; Katsuno T; Kato N; Ishimoto T; Yuzawa Y; Maruyama S; Kadomatsu K Am J Pathol; 2019 Jul; 189(7):1338-1350. PubMed ID: 31014956 [TBL] [Abstract][Full Text] [Related]
19. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079 [TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria. Dai C; Saleem MA; Holzman LB; Mathieson P; Liu Y Kidney Int; 2010 Jun; 77(11):962-73. PubMed ID: 20375988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]